Home > Cashflow Statement > AJANTA PHARMA

AJANTA PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-1,051 Cr₹-108 Cr₹-460 Cr₹-318 Cr₹-129 Cr

What is the latest Cash Flow from Financing Activities ratio of AJANTA PHARMA ?

The latest Cash Flow from Financing Activities ratio of AJANTA PHARMA is ₹-1,051 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-1,051 Cr
Mar2023₹-108 Cr
Mar2022₹-460 Cr
Mar2021₹-318 Cr
Mar2020₹-129 Cr

How is Cash Flow from Financing Activities of AJANTA PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-1,051 Cr
Negative
Mar2023 ₹-108 Cr
Negative
Mar2022 ₹-460 Cr
Negative
Mar2021 ₹-318 Cr
Negative
Mar2020 ₹-129 Cr -

Compare Cash Flow from Financing Activities of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹33,951.6 Cr 5.7% -5.3% 24.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,132.0 Cr 2.2% -5.8% 22.9% Stock Analytics
DIVIS LABORATORIES ₹149,254.0 Cr 4.1% -7% 52% Stock Analytics
CIPLA ₹116,123.0 Cr 1.3% -4.8% 9.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,573.0 Cr 2.2% -10.9% -0.6% Stock Analytics
ZYDUS LIFESCIENCES ₹97,966.9 Cr 7% -0.2% 27.5% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

5.7%

-5.3%

24.4%

SENSEX

2.8%

-3.1%

9%


You may also like the below Video Courses